- TLDR Biotech
- Archive
- Page 4
The Latest Biotech & Pharma Updates
Biotech & Pharma Updates | July 10 - 11, 2024
Pfizer's one-daily obesity pill moves forward, Illumina competitor lands $277M Series D, Novo Nordisk once-weekly insulin injection rejected by FDA, Novartis to shutter San Diego R&D site, and FTC sues Pharmacy Benefit Managers over insulin prices
Biotech & Pharma Updates | July 2 - 4, 2024
Beacon Therapeutics raises $170M Series B, Pentixapharm acquires Glycotope's antibody discovery arm, J&J lands FDA and EMA approval for multi-drug resistant TB therapy, and CureVac sells its Covid-19/flu assets while also laying off 30% of their staff
Biotech & Pharma Updates | June 28 - July 1, 2024
Eli Lilly makes another radiopharma deal, Samsung's Stelara biosimilar gets FDA approval, Boehringer Ingelheim begins Ph1 for "first-in-class" obesity treatment, Takeda sheds over 200 MA-based staffers, and lone Ph1 ultra-rare disease gene therapy patient makes stellar improvements
Biotech & Pharma Updates | June 27 - 30, 2024
Abbvie, Regeneron, Merck & Co. all land CHMP panel recommendations (while Apellis and PTC both get thumbs down), Lantheus buys radiophama assets, Ensho Therapeutics launches with Eisai assets, and former Cassava Sciences scientific advisor gets indicted
Biotech & Pharma Updates | June 26 - 27, 2024
Novo Nordisk buys 2seventy bio's hemophilia A asset, worm-derived therapies raise $16M, Abbvie buys Celsius Therapeutics for $250M, Kite Pharma to evaluate Cellares' cell therapy manufacturing platform, and Merck, Daiichi Sankyo's lung cancer mAb hit with FDA CRL